InterWest Venture Management’s Dare Bioscience DARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$28.7K Hold
5,172
0.14% 5
2023
Q2
$56.5K Hold
5,172
0.23% 5
2023
Q1
$64.5K Hold
5,172
0.31% 5
2022
Q4
$51.5K Hold
5,172
0.25% 5
2022
Q3
$62K Hold
5,172
0.19% 8
2022
Q2
$76K Hold
5,172
0.14% 8
2022
Q1
$92K Hold
5,172
0.04% 9
2021
Q4
$124K Hold
5,172
0.07% 9
2021
Q3
$104K Buy
5,172
+975
+23% +$19.2K 0.04% 10
2021
Q2
$95K Hold
4,197
0.03% 10
2021
Q1
$85K Hold
4,197
0.02% 12
2020
Q4
$67K Hold
4,197
0.01% 13
2020
Q3
$50K Hold
4,197
0.01% 12
2020
Q2
$50K Hold
4,197
0.04% 11
2020
Q1
$43K Hold
4,197
0.05% 12
2019
Q4
$41K Buy
+4,197
New +$40.9K 0.02% 12

Other funds holding DARE

InterWest Venture Management's DARE Position: Q3 2023 in Review

InterWest Venture Management held its Dare Bioscience (DARE) position steady in Q3 2023 at 5,172 shares worth $28.7K. The position accounts for 0.14% of the portfolio, ranked #5.

InterWest Venture Management first reported a position in DARE in Q4 2019 and has held it in 16 quarters since. The position peaked at $124K in Q4 2021. 30 funds tracked by Wall St. Rank hold DARE as of Q3 2023.

  • InterWest Venture Management held 5,172 shares of Dare Bioscience worth $28.7K as of Q3 2023.
  • InterWest Venture Management left its Dare Bioscience share count unchanged in Q3 2023.
  • Dare Bioscience made up 0.14% of InterWest Venture Management's portfolio in Q3 2023, its #5 holding.
  • InterWest Venture Management first reported a position in Dare Bioscience in Q4 2019 and has held it in 16 quarters since.
  • InterWest Venture Management's Dare Bioscience position peaked at $124K in Q4 2021.
  • 30 funds tracked by Wall St. Rank held Dare Bioscience as of Q3 2023.

Based on InterWest Venture Management's 13F filing for Q3 2023, filed 20 Oct 2023.